Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) Debt Ratio: 2019-2022

Historic Debt Ratio for Pharming Group N.V (PHAR) over the last 2 years, with Sep 2022 value amounting to 0.37.

  • Pharming Group N.V's Debt Ratio rose 38750.60% to 0.37 in Q3 2022 from the same period last year, while for Sep 2022 it was 0.37, marking a year-over-year increase of 477.20%. This contributed to the annual value of 0.00 for FY2021, which is 100.00% down from last year.
  • As of Q3 2022, Pharming Group N.V's Debt Ratio stood at 0.37, which was up 96,827.23% from 0.00 recorded in Q2 2022.
  • In the past 5 years, Pharming Group N.V's Debt Ratio ranged from a high of 60.25 in Q4 2020 and a low of 0.00 during Q2 2022.
  • Over the past 3 years, Pharming Group N.V's median Debt Ratio value was 0.00 (recorded in 2021), while the average stood at 7.64.
  • In the last 5 years, Pharming Group N.V's Debt Ratio surged by 39,054.41% in 2020 and then slumped by 100.00% in 2021.
  • Over the past 4 years, Pharming Group N.V's Debt Ratio (Quarterly) stood at 0.15 in 2019, then skyrocketed by 39,054.41% to 60.25 in 2020, then plummeted by 100.00% to 0.00 in 2021, then spiked by 38,750.60% to 0.37 in 2022.
  • Its last three reported values are 0.37 in Q3 2022, 0.00 for Q2 2022, and 0.00 during Q1 2022.